[HTML][HTML] RETRACTED: engineered whole organs and complex tissues

SF Badylak, DJ Weiss, A Caplan, P Macchiarini - The Lancet, 2012 - thelancet.com
End-stage organ failure is a key challenge for the medical community because of the ageing
population and the severe shortage of suitable donor organs available. Equally, injuries to …

From stem cells and cadaveric matrix to engineered organs

DA Taylor - Current opinion in biotechnology, 2009 - Elsevier
The definitive treatment for end-stage heart failure, organ transplant, is limited by the supply
of donor organs. Successful allograft recipients suffer significant adverse effects from chronic …

Immune response to stem cells and strategies to induce tolerance

P Batten, NA Rosenthal… - … Transactions of the …, 2007 - royalsocietypublishing.org
Although recent progress in cardiovascular tissue engineering has generated great
expectations for the exploitation of stem cells to restore cardiac form and function, the …

Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells

AG Zenovich, BH Davis, DA Taylor - Bone Marrow-Derived Progenitors, 2007 - Springer
Anincreasing number of patients living with cardiovascular disease (CVD) and still
unacceptably high mortality created an urgent need to effectively treat and prevent disease …